Related Experiment Video
Updated: Feb 28, 2026
Therapeutic Effectiveness of a Dietary Supplement for Management of Halitosis in Dogs
Published on: July 6, 2015
Immediate Effect of Modified Bhramari Pranayama on Salivary Nitric Oxide Level among Type 2 Diabetes Mellitus with
Geethashree Poojary1, Shivaprasad Shetty1, Prashanth Shetty2
1Department of Yoga, SDM College of Naturopathy and Yogic Sciences, Ujire, Karnataka, India.
Background:
Type 2 diabetes mellitus (T2DM) is frequently associated with xerostomia, a condition characterized by reduced salivary flow and a sensation of dry mouth. Nitric oxide (NO) plays a vital role in vasodilation and immune modulation. Modified Bhramari Pranayama (MBhrP), a specific yogic breathing technique, has been reported to enhance endogenous NO production.
Objective:
The primary aim of this study was to assess the immediate effect of MBhrP on salivary NO levels in T2DM individuals with xerostomia. The secondary objective was to evaluate its effect on heart rate variability (HRV), an indicator of autonomic nervous system activity.
Methodology:
Sixty-eight eligible participants were randomized into two groups: MBhrP group (n = 34) and the control group (n = 34). Participants were assessed using a close-ended questionnaire, including the Fox test and Xerostomia Inventory, to confirm the presence and severity of xerostomia. The intervention group performed MBhrP for 20 min between 6 AM and 7 AM, while the control group engaged in slow breathing for the same duration. Salivary NO levels and HRV parameters were assessed at baseline and immediately postintervention.
Results:
The MBhrP group showed a statistically significant increase in salivary NO levels compared to the control group (P < 0.05). HRV parameters SDRR (P = 0.02), root mean square of successive differences (P < 0.001), and pRR50 (P = 0.004) also showed significant improvement.
Conclusion:
MBhrP appears to have an immediate beneficial effect on salivary NO levels and autonomic function in T2DM patients with xerostomia, suggesting its potential as a nonpharmacological therapeutic tool.
More Related Videos
Related Concept Videos
01:23Drugs Acting on Autonomic Ganglia: Stimulants
Ganglionic stimulants activate NM nicotinic receptors in autonomic ganglia, falling into two categories: nicotine mimetics [e.g., lobeline, dimethylpiperazine, tetramethylammonium] and muscarinic receptor agonists [e.g., muscarine, methacholine]. The first category's action is rapid and blocked by nicotinic receptor antagonists, while the second category's action is delayed and blocked by atropine-like agents. Nicotine, an alkaloid, affects the heart rate by stimulating...
01:16Antianginal Drugs: Nitrates and β-Blockers
Organic nitrates, such as nitroglycerin, play a pivotal role. Once metabolized, they liberate nitric oxide, a molecular marvel. Nitric oxide triggers guanylyl cyclase and augments cGMP production. This biochemical cascade orchestrates the relaxation of vascular smooth muscles, ushering in vasodilation and enhancing coronary blood flow....
01:23Antihypertensive Drugs: Vasodilators